Rhiannon Braund

Rhiannon Braund
Rhiannon Braund
Nationality	New Zealand
Alma mater	University of Otago
	Scientific career
Institutions	University of Otago
Thesis	Development of a Topical Growth Factor Formulation for Wound Healing (2008); ;
Doctoral advisor	Natalie Medlicott

Rhiannon Braund is a New Zealand academic and registered pharmacist. She is a professor in the Department of Preventive and Social Medicine at the University of Otago.

Scholia has a profile for Rhiannon Braund (Q91720529).

Academic career edit

Braund completed a BSc, BPharm and PhD (2008)^[1] at the University of Otago and is a registered pharmacist.^[2] Her doctoral advisor was Natalie Medlicott.^[1] In December 2019 she was promoted to full professor at Otago, with effect from 1 February 2020.^[3]

In 2018 Braund was elected Fellow of the Pharmaceutical Society of New Zealand^[4] and became president of the Society in December 2020.^[5]^[6]

Selected works edit

Books edit

Peake, Barrie M.; Braund, Rhiannon; Tong, Alfred Y. C.; Tremblay, Louis A. (2015). The life-cycle of pharmaceuticals in the environment. Amsterdam: Woodhead Publishing. ISBN 978-1-908818-45-4. OCLC 929851505.
Braund, Rhiannon, ed. (2020). Renal medicine and clinical pharmacy. Cham: Springer. ISBN 978-3-030-37655-0. OCLC 1164583284.

Journal articles edit

Rhiannon Braund; Courtney K Lawrence; Lindsay Baum; Brittany Kessler; Madison Vassart; Carolyn Coulter (18 January 2019). "Quality of electronic records documenting adverse drug reactions within a hospital setting: identification of discrepancies and information completeness". The New Zealand Medical Journal. 132 (1488): 28–37. ISSN 0028-8446. PMID 31851659. Wikidata Q92085317.
Sivamanoj Yadav Boyina; Tim Stokes; Angela Renall; Rhiannon Braund (1 March 2020). "Clinical pharmacist facilitators in primary care: a descriptive study of their roles and services provided in general practices of southern New Zealand". Journal of Primary Health Care. 12 (1): 88–95. doi:10.1071/HC19073. ISSN 1172-6156. PMID 32223855. Wikidata Q90729913.
Nagham J Ailabouni; Sarah N Hilmer; Lisa Kalisch; Rhiannon Braund; Emily Reeve (30 April 2020). "COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy". The Journals of Gerontology. doi:10.1093/GERONA/GLAA104. ISSN 1758-535X. PMC 7197623. PMID 32353109. Wikidata Q94468903.
Caryn Thomas; Rhiannon Braund; Helen Paterson (31 July 2020). "Management of short supply oral contraceptives". The New Zealand Medical Journal. 133 (1519): 128–129. ISSN 0028-8446. PMID 32777806. Wikidata Q98299996.
Hunter Robson; Rhiannon Braund; Michelle Glass; Janelle Ashton; Michael Tatley (6 November 2020). "Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre". Clinical Toxicology: 1–8. doi:10.1080/15563650.2020.1828592. ISSN 1556-3650. PMID 33156704. Wikidata Q101406738.

References edit

^ ^a ^b Braund, Rhiannon (2008). Development of a Topical Growth Factor Formulation for Wound Healing (Doctoral thesis). OUR Archive, University of Otago. hdl:10523/4749.
^ "Profile: Professor Rhiannon Braund". University of Otago. Archived from the original on 7 February 2021. Retrieved 1 February 2021.
^ "30 new Professors for the University of Otago". University of Otago. 10 December 2019. Archived from the original on 18 January 2021. Retrieved 1 February 2021.
^ "Top honour for Otago Pharmacist". University of Otago. 24 July 2018. Archived from the original on 6 February 2021. Retrieved 1 February 2021.
^ "Pharmaceutical president". Otago Daily Times Online News. 3 December 2020. Archived from the original on 22 January 2021. Retrieved 1 February 2021.
^ Chilton Towle, Jonathan (30 November 2020). "Pharmaceutical Society elects new president". Pharmacy Today. Archived from the original on 8 February 2021. Retrieved 1 February 2021.